共 63 条
[1]
Belloni B(2008)Low-dose anti-IgE in patients with atopic eczema with high serum IgE levels J Allergy Clin Immunol 120 1223-1225
[2]
Ziai M(2008)Atopic dermatitis N Engl J Med 358 1483-94
[3]
Lim A(2005)The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma Allergy 60 302-308
[4]
Lemercier B(1994)Dermatology life quality Index (DLQI): A simple practical measure for routine clinical use Clinical and Experimental Dermatology 19 210-216
[5]
Sbornik M(2009)The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update Resp Med 103 1098-1113
[6]
Weidinger S(2005)Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE Allergy 60 309-316
[7]
Bieber T(2008)Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis Monaldi Arch Chest Dis 69 78-80
[8]
Bousquet J(2005)Failure of Omalizumab for treatment of severe adult atopic dermatitis J Am Acad Dermatol 35 338-340
[9]
Cabreba P(2006)Treatment of recalcitrant atopic dermatitis with Omalizumab J Am Acad Dermatol 54 68-72
[10]
Berkman N(2007)The IgE repertoire in PBMCs of atopic patients is characterized by individual reaarangements without variable region of the heavy immunoglobulin chain bias J Allergy Clin Immunol 120 696-706